These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2496014)

  • 21. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for breast cancer and cost-effectiveness of thermal diagnostic techniques.
    Berger GS; Keith LG
    Prog Clin Biol Res; 1982; 107():839-49. PubMed ID: 6820147
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk- and cost-benefit analyses of breast screening programs derived from absorbed dose measurements in The Netherlands.
    Zuur C; Broerse JJ
    Diagn Imaging Clin Med; 1985; 54(3-4):211-22. PubMed ID: 3928229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comments and response on the USPSTF recommendation on screening for breast cancer.
    Begg CB
    Ann Intern Med; 2010 Apr; 152(8):540-1; author reply 543-4. PubMed ID: 20157101
    [No Abstract]   [Full Text] [Related]  

  • 25. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Breast cancer screening. Objectives of a professional structure].
    Taïeb A
    Bull Acad Natl Med; 1998; 182(8):1669-72. PubMed ID: 10188313
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of screening programme on mortality from breast cancer. Investment in treatment would be more cost effective.
    Baum M; Tobias JS
    BMJ; 2000 Dec; 321(7275):1528. PubMed ID: 11118189
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-cost screening mammography.
    North C
    AJR Am J Roentgenol; 1992 Aug; 159(2):431; author reply 431-2. PubMed ID: 1632375
    [No Abstract]   [Full Text] [Related]  

  • 29. Mammography screening under 50: a limited perspective on a multifaceted issue.
    Royak-Schaler R; Gallant SJ; Klabunde CN
    Womens Health; 1996; 2(4):243-9; discussion 261-6. PubMed ID: 9421559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsidizing screening mammography through induced revenues and profits.
    Krug H
    Radiol Manage; 1990; 12(4):28-33. PubMed ID: 10108487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-cost screening mammography.
    Evens RG
    AJR Am J Roentgenol; 1992 Aug; 159(2):430-1; author reply 431-2. PubMed ID: 1307858
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In the clinic. Breast cancer screening and prevention.
    Nattinger AB
    Ann Intern Med; 2010 Apr; 152(7):ITC41. PubMed ID: 20368645
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-cost screening mammography: report on finances and review of 21,716 consecutive cases.
    Bird RE
    Radiology; 1989 Apr; 171(1):87-90. PubMed ID: 2494683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revolution follows the breast cancer epidemic.
    Evans N
    Revolution; 1996; 6(2):30-1. PubMed ID: 9043377
    [No Abstract]   [Full Text] [Related]  

  • 36. [Breast cancer screening lacks effectiveness].
    Merkelbach JW
    Ned Tijdschr Geneeskd; 2002 Jan; 146(3):139-40. PubMed ID: 11826675
    [No Abstract]   [Full Text] [Related]  

  • 37. [Critical notes on the risk/benefit/cost discussion in mammography from the clinical point of view].
    Frischbier HJ; Würthner K
    Strahlenschutz Forsch Prax; 1977; 18():95-100. PubMed ID: 414383
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening mammography for women under 50: considerations for fully informed decision making.
    Ernster VL
    Womens Health; 1996; 2(4):257-60; discussion 261-6. PubMed ID: 9453858
    [No Abstract]   [Full Text] [Related]  

  • 39. Counting the costs of mammography screening: first year results from the Sydney study.
    Med J Aust; 1990 Aug; 153(3):174-6. PubMed ID: 2377128
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary on "Mammography screening: prospects and opportunity costs".
    Mettlin C
    Womens Health; 1996; 2(4):251-5; discussion 261-6. PubMed ID: 9453857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.